Advertisement

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study

  • Dan Călugăru
  • Mihai Călugăru
Letter to the Editor

Dear Editor:

We would like to address several challenges that arise from the study by Li et al. [1].

There was a selection bias attributable to encompass in the study of two completely different etiologic subgroups of patients, namely, patients older than 50 years, who usually have common systemic conditions such as hypertension and diabetes and patients younger than 50 years, where other mechanisms, such as the hyperviscosity syndrome or inflammatory condition, should be specifically considered. Likewise, the inclusion in the study of two types of retinal vein occlusions (RVOs), for example, branch RVO and central RVO, was inappropriate because they have different etiology, pathogenesis, and prognosis [2, 3, 4]. Additionally, the therapeutic decisions were at the discretion of the investigator physicians in the 13 study sites. Taken together, these findings may have confounded the results.

The following relevant data are missing from the study: the age stratification...

Notes

Compliance with ethical standards

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. Both authors (D.C and M.C) were involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The authors have full control over the primary data and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data if requested.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Li X, Wang N, Liang X et al (2018) Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study. Graefes Arch Clin Exp Ophthalmol 256:59–69CrossRefPubMedGoogle Scholar
  2. 2.
    Călugăru D, Călugăru M (2016) Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex) in its treatment. Graefes Arch Clin Exp Ophthalmol 254:2477–2478CrossRefPubMedGoogle Scholar
  3. 3.
    Călugăru D, Călugăru M (2017) Baseline choroidal thickness as a predictor for treatment outcomes in central retinal vein occlusion. Am J Ophthalmol 176:257–258PubMedCrossRefGoogle Scholar
  4. 4.
    Călugăru D, Călugăru M (2017) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with macular edema secondary to vein occlusion. Am J Ophthalmol 184:190–191CrossRefPubMedGoogle Scholar
  5. 5.
    Kuppermann BD, Haller JA, Bandello F (2014) Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macula edema due to retinal vein occlusion. Retina 34:1743–1749CrossRefPubMedGoogle Scholar
  6. 6.
    Călugăru D, Călugăru M (2017) Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol 255:427–428CrossRefPubMedGoogle Scholar
  7. 7.
    Călugăru D, Călugăru M (2017) Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France. Graefes Arch Clin Exp Ophthalmol 255:211–212CrossRefPubMedGoogle Scholar
  8. 8.
    Călugăru D, Călugăru M (2015) Intravitreal bevacixumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 31:78–86CrossRefPubMedGoogle Scholar
  9. 9.
    Călugăru D, Călugăru M (2017) Ranibizumab for retinal vein occlusion. Predictive factors and long-term outcomes in real-life data Retina 37:e84–e86Google Scholar
  10. 10.
    Călugăru D, Călugăru M, Yeh RE et al (2015) Ophthalmic technology assessment: Therapies for macular edema associated with central retinal vein occlusion: A report by the American Academy of Ophthalmology. Ophthalmology 122:e65–e66CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of OphthalmologyUniversity of MedicineCluj-NapocaRomania

Personalised recommendations